← Browse by Condition
Medical Condition

metastatic triple negative breast carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05770531 Phase 2
Recruiting

Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy

Enrollment
160 pts
Location
United States
Sponsor
Vanderbilt-Ingram Cancer Cente...
View Trial →